Rudolf Jeffrey D, Dong Liao-Bin, Shen Ben
Department of Chemistry, The Scripps Research Institute, Jupiter, FL 33458, United States.
Department of Chemistry, The Scripps Research Institute, Jupiter, FL 33458, United States; Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL 33458, United States; Natural Products Library Initiative at The Scripps Research Institute, Jupiter, FL 33458, United States.
Biochem Pharmacol. 2017 Jun 1;133:139-151. doi: 10.1016/j.bcp.2016.11.013. Epub 2016 Nov 16.
Natural products have served as the main source of drugs and drug leads, and natural products produced by microorganisms are one of the most prevalent sources of clinical antibiotics. Their unparalleled structural and chemical diversities provide a basis to investigate fundamental biological processes while providing access to a tremendous amount of chemical space. There is a pressing need for novel antibiotics with new mode of actions to combat the growing challenge of multidrug resistant pathogens. This review begins with the pioneering discovery and biological activities of platensimycin (PTM) and platencin (PTN), two antibacterial natural products isolated from Streptomyces platensis. The elucidation of their unique biochemical mode of action, structure-activity relationships, and pharmacokinetics is presented to highlight key aspects of their biological activities. It then presents an overview of how microbial genomics has impacted the field of PTM and PTN and revealed paradigm-shifting discoveries in terpenoid biosynthesis, fatty acid metabolism, and antibiotic and antidiabetic therapies. It concludes with a discussion covering the future perspectives of PTM and PTN in regard to natural products discovery, bacterial diterpenoid biosynthesis, and the pharmaceutical promise of PTM and PTN as antibiotics and for the treatment of metabolic disorders. PTM and PTN have inspired new discoveries in chemistry, biology, enzymology, and medicine and will undoubtedly continue to do so.
天然产物一直是药物和药物先导物的主要来源,微生物产生的天然产物是临床抗生素最普遍的来源之一。它们无与伦比的结构和化学多样性为研究基本生物学过程提供了基础,同时也为进入大量化学空间提供了途径。迫切需要具有新作用模式的新型抗生素来应对多重耐药病原体日益增长的挑战。本综述首先介绍了从浅蓝链霉菌中分离出的两种抗菌天然产物——扁枝衣霉素(PTM)和扁枝菌素(PTN)的开创性发现及其生物活性。阐述了它们独特的生化作用模式、构效关系和药代动力学,以突出其生物活性的关键方面。然后概述了微生物基因组学如何影响PTM和PTN领域,并揭示了在萜类生物合成、脂肪酸代谢以及抗生素和抗糖尿病治疗方面的范式转变发现。最后讨论了PTM和PTN在天然产物发现、细菌二萜生物合成以及PTM和PTN作为抗生素和治疗代谢紊乱药物的药学前景方面的未来展望。PTM和PTN激发了化学、生物学、酶学和医学领域的新发现,无疑将继续如此。